未登录

P

Ping Li

Shandong University of Traditional Chinese Medicine

H指数:19

被引数:1,047

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antiviral effects and mechanism of Qi pi pill against influenza viruses

芪脾丸抗流感病毒作用及机制研究

ANIMAL MODELS AND EXPERIMENTAL MEDICINE

IF3.4

2025-01-260

OAAI

Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-12-070

PRE

Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-12-013

PRE

Self-Assembled Virus-Like Particle Vaccines via Fluorophilic Interactions Enable Infection Mimicry and Immune Protection

ADVANCED HEALTHCARE MATERIALS

IF9.6

2023-09-2211

PRE

Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-07-253

PRE

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

IF4.9

2022-08-0414

OAAI

Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-11-0416

OA

Non-neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system

使用或不使用AS03佐剂系统的A(H1N1)pdm09流感疫苗接种后的非中和抗体反应

INFLUENZA AND OTHER RESPIRATORY VIRUSES

IF4.2

2020-09-055

OAAI

Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors

新型流感病毒神经氨酸酶抑制剂的鉴定

FRONTIERS IN MICROBIOLOGY

IF4.5

2020-02-2837

OAAI

A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus

IF3.5

2019-09-0516

OAAI

Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase

表达Gaussia荧光素酶的重配甲型H3N2流感病毒的产生

IF3.5

2019-07-207

OAAI

A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase

IF3.5

2018-06-1317

OAAI

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons

LANCET CHILD & ADOLESCENT HEALTH

IF15.5

2018-05-0151

OAAI

Claeys, Carine; Zaman, Khalequ; Dbaibo, Ghassan; Li, Ping; Izu, Allen; Kosalaraksa, Pope; Rivera, Luis; Acosta, Beatriz; Arroba Basanta, Maria Luisa; Aziz, Asma; Angel Cabanero, Miguel; Chandrashekaran, Vijayalakshmi; Corsaro, Bartholomew; Cousin, Luis; Diaz, Adolfo; Diez-Domingo, Javier; Dinleyici, Ener Cagri; Faust, Saul N.; Friel, Damien; Garcia-Sicilia, Jose; Gomez-Go, Grace D.; Antoinette Gonzales, Maria Liza; Hughes, Stephen M.; Jackowska, Teresa; Kant, Shashi; Lucero, Marilla; Malvaux, Ludovic; Mares Bermudez, Josep; Martinon-Torres, Federico; Miranda, Mariano; Montellano, May; Peix Sambola, Maria Amor; Prymula, Roman; Puthanakit, Thanyawee; Ruzkova, Renata; Sadowska-Krawczenko, Iwona; Salamanca de la Cueva, Ignacio; Sokal, Etienne; Soni, Jyoti; Szymanski, Henryk; Ulied, Angels; Schuind, Anne; Jain, Varsha K.; Innis, Bruce L.

Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

灭活四价流感疫苗优化生产工艺的评估: 儿童和成人的III期随机双盲安全性和免疫原性研究

BMC INFECTIOUS DISEASES

IF3

2018-04-185

OAAI

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

AS03-Adjuvanted H7N9大流行性流感疫苗在健康成人中随机试验的免疫原性和安全性

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2016-09-0745

OAAI

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: Pooled analysis of 28 clinical trials

成人接种AS03-adjuvanted灭活裂解病毒体A(H1N1)pdm09和H5N1流感病毒疫苗的安全性: 28项临床试验的汇总分析

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-11-2124

OAAI

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-10-2710

OAAI

Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine An open-label, randomized trial in Japanese children aged 6 months to 17 years

肌肉注射AS03-adjuvanted H1N1 2009流感疫苗6个月后免疫应答的安全性和持续性一项针对6个月至17岁日本儿童的开放标签随机试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-10-278

OAAI

Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study

先前接种过季节性流感疫苗的参与者对A(H1N1)pdm09流感疫苗的反应: 一项随机，观察盲，对照研究

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2014-05-2612

OAAI

Noninvasive Visualization of Respiratory Viral Infection Using Bioorthogonal Conjugated Near-Infrared-Emitting Quantum Dots

IF16

2014-05-0962

PREAI